Continued research efforts aimed at identifying vulnerable brain targets of alcohol teratogenicity are essential. Establishing relationships between brain alterations and quantity of alcohol exposure, facial dysmorphology and behavioral/cognitive deficits will aid in the identification of unique and specific brain markers of exposure. Such markers are needed to aid in the diagnostic process and for discerning novel and specific treatment strategies. Research suggests that earlier identification and diagnosis with a FASD may help in reducing the chance of adverse life outcomes among individuals with prenatal alcohol exposure [72]. Continued research aimed at understanding the relationship between alcohol-induced brain development disruption and the associated functional deficits may also help in developing novel brain-based treatments and interventions for individuals with FASD.